RemedyRepack Inc. is recalling 33 blister cards (a total of 990 tablets) of Losartan (50mg), a medication used to treat high blood pressure. The recall was initiated because the active ingredient in the medication was found to contain trace amounts of N-Methylnitrosobutyric acid (NMBA), an unexpected impurity. This impurity was detected during testing, though no specific patient injuries or adverse events have been reported to date for this specific lot.
NMBA is a suspected human carcinogen. Exposure to this impurity over a long period of time may increase the risk of developing cancer, although the immediate risk from short-term use is generally low.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.